Technical 200dma bullish cross, page-10

Glad to have you still onboard @idean . Great soaking at these levels >5c past few sessions in a very good biotech market. I have not been a holder for as long but I too was drawn to the 'gold standard' cardiovascular technology. The initial devices were great, however the very high price-point made it difficult for the company to achieve true scale. The move by current management to pivot to the wearables market and miniaturised devices makes a lot of sense to me, and the potential monetisation of the core IP is now huge.

All IMO.

GLTA Holders.